HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$1.52
Day range
$1.31 - $1.43
Year range
$0.44 - $3.17
Market cap
6.22M USD
Avg Volume
11.95K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 8.76M | -28.78% |
Operating expense | 4.29M | -23.34% |
Net income | 911.00K | -45.64% |
Net profit margin | 10.40 | -23.70% |
Earnings per share | — | — |
EBITDA | 1.26M | -47.38% |
Effective tax rate | -1.10% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.42M | -32.65% |
Total assets | 12.04M | -14.27% |
Total liabilities | 12.33M | -51.03% |
Total equity | -298.00K | — |
Shares outstanding | 4.43M | — |
Price to book | -21.77 | — |
Return on assets | 23.49% | — |
Return on capital | 146.76% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 911.00K | -45.64% |
Cash from operations | 1.94M | -8.41% |
Cash from investing | -117.00K | 77.59% |
Cash from financing | -900.00K | 40.00% |
Net change in cash | 921.00K | 879.79% |
Free cash flow | 1.69M | 53.42% |
About
Founded
1986
Headquarters
Website
Employees
111
